Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis

Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis

BackgroundGastrointestinal cancers are the most common malignant tumors worldwide. As the improvement of survival by surgical resection alone for cancers is close to the bottleneck, recent neoadjuvant therapy has been emphasized and applied in the treatment. Despite the advantage on improving the pr...

Full description

Bibliographic Details
Main Authors:	Xin-Yi Xu, Xiao-Man Jiang, Qin Xu, Hao Xu, Jin-Hua Luo, Cui Yao, Ling-Yu Ding, Shu-Qin Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Oncology
Subjects:	skeletal muscle mass (SMM) neoadjuvant therapy (NAT) prognosis gastrointestinal cancers (GI cancers) meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.892935/full

Similar Items

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST
by: Ping’an Ding, et al.
Published: (2022-08-01)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
by: Han Gyul Yoon, et al.
Published: (2020-04-01)

Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy
by: Wang Yang, et al.
Published: (2024-01-01)

Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta‐analysis
by: Yue Jin, et al.
Published: (2023-04-01)

The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers
by: Aoyang Yu, et al.
Published: (2023-10-01)

Skeletal Muscle Mass Has Stronger Association With the Risk of Hyperuricemia Than Body Fat Mass in Obese Children and Adolescents
by: Luyao Xie, et al.
Published: (2022-03-01)

Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis
by: Xiaohong He, et al.
Published: (2023-04-01)

Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
by: Jiuzhou Chen, et al.
Published: (2022-08-01)

Predicting the Early Response to Neoadjuvant Therapy with Breast MR Morphological, Functional and Relaxometry Features—A Pilot Study
by: Roxana Pintican, et al.
Published: (2022-11-01)

The efficacy of fat-free mass index and appendicular skeletal muscle mass index in cancer malnutrition: a propensity score match analysis
by: Wei Ji, et al.
Published: (2023-07-01)

Management of gastrointestinal smooth muscle tumors: Seven years experience of a teaching hospital in Saudi Arabia
by: Al Salamah Saleh, et al.
Published: (2000-01-01)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
by: Nobuya Daitoku, et al.
Published: (2022-09-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

Skeletal Muscle Changes Assessed by Preoperative Computed Tomography Images Can Predict the Long‐Term Prognosis of Stage III Colorectal Cancer
by: Keigo Yokoi, et al.
Published: (2022-05-01)

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
by: Byung Min Lee, et al.
Published: (2021-04-01)

Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
by: Hualin Chen, et al.
Published: (2022-08-01)

Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers
by: Amirhossein Davoodvandi, et al.
Published: (2021-08-01)

Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis
by: Zhi-Feng Miao, et al.
Published: (2018-01-01)

Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis
by: Zhen Liu, et al.
Published: (2022-08-01)

Relationships between the Salivary Microbial Composition and Gastrointestinal Diseases
by: Asal Norouzpour, et al.
Published: (2022-07-01)

Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm
by: Muhammet Ozer, et al.
Published: (2023-07-01)

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01)

Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer
by: In Kyu Park, et al.
Published: (2021-12-01)

Association of longitudinal changes in skeletal muscle mass with prognosis and nutritional intake in acutely hospitalized patients with abdominal trauma: a retrospective observational study
by: Fengchan Xi, et al.
Published: (2023-05-01)

Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers
by: Bojana Ristic, et al.
Published: (2021-05-01)

Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
by: In-Ho Kim, et al.
Published: (2021-01-01)

Assessment of Functional and Nutritional Status and Skeletal Muscle Mass for the Prognosis of Critically Ill Solid Cancer Patients
by: Clara Vigneron, et al.
Published: (2022-11-01)

Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
by: Hye-Sol Jung, et al.
Published: (2022-09-01)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
by: Arthur Peyrottes, et al.
Published: (2021-07-01)

Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
by: Atilla Soran, et al.
Published: (2019-10-01)

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
by: Cui Jiang, et al.
Published: (2019-09-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Chemotherapy-Induced Molecular Changes in Skeletal Muscle
by: Mafalda Barbosa Pedrosa, et al.
Published: (2023-03-01)

Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Bingjie Guan, et al.
Published: (2023-11-01)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
by: Jin Wu, et al.
Published: (2022-10-01)

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Oktay Üçer
Published: (2016-04-01)

The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
by: Laura F. J. Huiskamp, et al.
Published: (2020-11-01)

Impact of Preoperative Skeletal Muscle Mass and Quality on the Survival of Elderly Patients After Curative Resection of Colorectal Cancer
by: Yasutomo Ojima, et al.
Published: (2019-10-01)

Small Bowel Gastrointestinal Bleeding Diagnosis and Management—A Narrative Review
by: B. Murphy, et al.
Published: (2019-05-01)

The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
by: Jinzhao Liu, et al.
Published: (2022-10-01)